| __timestamp | BioMarin Pharmaceutical Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 14683100000 |
| Thursday, January 1, 2015 | 737887000 | 14921500000 |
| Friday, January 1, 2016 | 907234000 | 15567200000 |
| Sunday, January 1, 2017 | 1071860000 | 16801100000 |
| Monday, January 1, 2018 | 1175948000 | 16811600000 |
| Tuesday, January 1, 2019 | 1344582000 | 17598300000 |
| Wednesday, January 1, 2020 | 1336183000 | 19056500000 |
| Friday, January 1, 2021 | 1375760000 | 21005600000 |
| Saturday, January 1, 2022 | 1612370000 | 21911600000 |
| Sunday, January 1, 2023 | 1842161000 | 27041900000 |
| Monday, January 1, 2024 | 36624400001 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, understanding the financial health of companies is crucial. Over the past decade, Eli Lilly and Company and BioMarin Pharmaceutical Inc. have shown distinct trends in their gross profit margins. From 2014 to 2023, Eli Lilly's gross profit surged by approximately 84%, reaching a peak in 2023. This growth reflects their strategic investments and successful product launches. In contrast, BioMarin's gross profit increased by nearly 196% over the same period, showcasing their robust pipeline and niche market focus. Despite BioMarin's impressive growth rate, Eli Lilly's gross profit remains significantly higher, underscoring its dominance in the sector. These trends highlight the dynamic nature of the pharmaceutical industry, where innovation and strategic positioning are key to financial success.
Eli Lilly and Company vs Novartis AG: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Eli Lilly and Company vs Zoetis Inc.
Eli Lilly and Company and Bristol-Myers Squibb Company: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Eli Lilly and Company and Walgreens Boots Alliance, Inc.
Key Insights on Gross Profit: Eli Lilly and Company vs MorphoSys AG
Gross Profit Comparison: Eli Lilly and Company and Evotec SE Trends
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis